Results 181 to 190 of about 176,228 (323)
Enlarged adrenal glands: the long-term consequence of Cushing’s disease [PDF]
, 2019 Yorihiro Iwasaki, Akihiro Hamasaki
openalex +1 more source
Novel approaches for drug development against chronic primary pain: A systematic review
British Journal of Pharmacology, EarlyView.Abstract Chronic primary pain (CPP) persisting for more than 3 months, associated with significant emotional distress without any known underlying cause, is an unmet medical need. Traditional or adjuvant analgesics do not provide satisfactory pain relief for a great proportion of these patients.
Valéria Tékus +5 more
wiley +1 more source
Editorial Disease of Adrenal Glands
, 2015 The adrenal gland has been historically an object of interest and scientific curiosity. This is also due to its very heterogeneous structure, number of hormones, complex neural innervation, and multiple and different physiological functions.
Iacobellis, Gianluca +3 more
openaire +1 more source
ADDISONIAN CRISIS DUE TO ADRENAL GLAND METASTASIS IN HODGKIN'S DISEASE [PDF]
, 2003 MN Akçay, SB Tekin, G Akçay
openalex +1 more source
British Journal of Pharmacology, EarlyView.Abstract Vascular toxicity is a growing concern in cancer patients receiving vascular endothelial growth factor inhibitor (VEGFi) therapy, posing a significant threat to patient prognosis. While the primary mechanism of VEGFi‐induced vascular toxicity is linked to redox‐sensitive reactions that disrupt vascular tone, leading to hypertension and ...
Grace Whelan, Karla B. Neves
wiley +1 more source
Presentation, disease progression and outcomes of adrenal gland metastases
, 2020 Jimmy Mao +3 more
openalex +2 more sources
Successful Grafting of Adrenal Gland in a Case of Addison's Disease [PDF]
, 1941 Fred Katz, Fritz Mainzer
openalex +1 more source
Functional scintigraphy of the adrenal gland.
European Journal of Endocrinology, 2002 D. Rubello +5 more
semanticscholar +1 more source
Cancer pain: current practice and emerging targets
British Journal of Pharmacology, EarlyView.Cancer pain (CP) arises from a complex interplay between the tumour and its microenvironment. Many patients experience a mixed pain phenotype that encompasses nociceptive, neuropathic and neuroinflammatory mechanisms, and vary across tumour type and disease stage. Despite decades of intensive research, the mainstay of cancer pain treatment is still non‐
Yi Ye +5 more
wiley +1 more source